Thomas Bengt Eldered

Thomas Bengt Eldered

Fondatore presso FLERIE INVEST AB

Patrimonio netto: 149 M $ in data 31/05/2026

66 anni
Health Technology
Finance
Commercial Services

Profilo

Mr. Thomas Bengt Eldered is an Independent Director at Xintela AB, a Chairman at Prokarium Holdings Ltd., a Chairman at Nanologica AB, a Chairman-Supervisory Board at Amarna Therapeutics BV, a Chairman at Recipharm Fontaine SAS, a Chairman at Flerie AB, a Chairman at Recipharm Monts SAS, a Chairman at B&E Participation, Inc., a Chairman at NorthX Biologics Matfors AB, a Chairman at Trimeta LLC, a Chairman of the board at Flerie Invest AB and a Chief Executive Officer at Consort Medical GmbH.
He is on the Board of Directors at Xintela AB, Prokarium Ltd., SymCel AB, Aesica Formulation Development Ltd., Aesica Holdco Ltd., B&E Invest AB, Bohus Biotech AB /Private Group/, Bohus HoldCo AB, Buzzard Pharmaceuticals AB, Chromafora AB, Cordivest AB, Cormorant Pharmaceuticals AB, Flerie Förvaltning AB, Flerie International AB, KAHR Medical Ltd., Pingvinen Penningplacering AB, Recipharm Holdings Ltd., Sixera Pharma AB, T&M Participation AB and Zentricity Holding AB. Mr. Eldered was previously employed as a Chairman by Cobra Biologics Holding AB, a Non-Executive Chairman by Cobra Biologics Ltd., a Vice President by Recip AB, a Factory Manager by Pharmacia AB, a Chairman by B&E Participation AB, a Deputy Director by Empros Pharma AB, and a Co-Managing Director by Recipharm Verwaltungs GmbH.
He also served on the board at Toleranzia AB, Recipharm Ltd., SwedenBIO Service AB, Recipharm AB, Backsell Eldered Holding AB, Flerie Participation AB, Provell Pharmaceuticals LLC, Roar BidCo AB, SwedenBIO Service AB and Zentricity International AB. He received his graduate degree from the University of Linköping.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
FLERIE AB
61,92%
20/05/2026 58.888.047 ( 61,92% ) 149 M $ 31/05/2026

Posizioni attive di Thomas Bengt Eldered

SocietàPosizioneInizio
NANOLOGICA AB Presidente 21/05/2026
XINTELA AB Direttore/Membro del Consiglio 01/01/2022
FLERIE INVEST AB Fondatore 01/01/2011
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio 04/02/2020
Direttore/Membro del Consiglio 04/02/2020
Presidente 20/03/2010
Presidente 30/04/2014
Direttore/Membro del Consiglio -
░░░░░░░ ░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░ -
░░░░░░░░░ ░░░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ -

Precedenti posizioni note di Thomas Bengt Eldered

SocietàPosizioneFine
░░░░░░ ░░░░░░░░░░░░░ ░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░░░░░░░░░░ ░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ -
░░░░░░░░░ ░░░░░░░ ░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Thomas Bengt Eldered

Formazione di Thomas Bengt Eldered

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

55

Relazioni di 1° grado

45

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private45

Distribution Services

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Finance

Health Technology

B&E Invest AB

Health Technology

Technology Services

Health Technology

Health Technology

Finance

Process Industries

Trimeta LLC

B&E Participation, Inc.

Pingvinen Penningplacering AB

Finance

Health Technology

Health Technology

Finance

Commercial Services

Health Services

Finance

Commercial Services

Miscellaneous

Finance

Health Technology

Cordivest AB

Finance

Health Technology

Finance

  1. Mercati
  2. Insiders
  3. Thomas Bengt Eldered